Long-term seizure remission in childhood absence epilepsy: might initial treatment matter?
Long-term seizure remission in childhood absence epilepsy: might initial treatment matter?
复制标题
DOI:
10.1111/epi.12551
复制
发表时间:
2014-04
期刊:
影响因子:
5.6
通讯作者:
Blumenfeld H
中科院分区:
文献类型:
--
作者:
Berg AT;Levy SR;Testa FM;Blumenfeld H
Examine the possible association between long-term seizure outcome in childhood absence epilepsy (CAE) and the initial treatment choice. Children with CAE were prospectively recruited at initial diagnosis and followed in a community-based cohort study. Children presenting with convulsive seizures, significant imaging abnormalities or who were followed <5 years were excluded. Early outcomes included success of initial medication, early remission, and pharmacoresistance. The primary long-term outcome was complete remission, ≥5 years both seizure and medication-free. Survival methods were used for analyses. The first medication was Ethosuximde (ESM ) in 41 (69%) and Valproic acid (VPA) in 18 (31%). Initial success rates were 59% (ESM) and 56% (VPA). Early remission and pharmacoresistance were similar in each group. Apart from atypical EEG features (61% (VPA), 17% (ESM )), no clinical features varied substantially between the treatment groups. Complete remission occurred in 31 (76%) children treated with ESM and 7 (39%) who received VPA (p=0.007). Children with versus without atypical EEG features were less likely to enter complete remission (50% vs. 71%, p=0.03). In a Cox regression, ESM was associated with a higher rate of complete remission than VPA (Hazards ration (HR)=2.5, 95% CI 1.1-6.0, p=0.03). Atypical EEG features did not independently predict outcome (p=0.15). Five- and 10-year remission, regardless of continued treatment, occurred more often in children initially treated with ESM versus VPA . These findings are congruent with results of studies in genetic absence models in rats and provide preliminary evidence motivating a hypothesis regarding potential disease modifying effects of ESM in childhood absence epilepsy.
登录
查看更多内容
DOI:
10.1056/nejmoa0902014
发表时间:
2010-03-04
期刊:
The New England journal of medicine
影响因子:
--
作者:
Glauser TA;Cnaan A;Shinnar S;Hirtz DG;Dlugos D;Masur D;Clark PO;Capparelli EV;Adamson PC;Childhood Absence Epilepsy Study Group
通讯作者:
Childhood Absence Epilepsy Study Group
DOI:
10.1016/0021-9681(79)90012-2
发表时间:
1979-01-01
期刊:
JOURNAL OF CHRONIC DISEASES
影响因子:
--
作者:
SACKETT, DL
通讯作者:
SACKETT, DL
影响因子:
14.5
作者:
Berg, Anne T.;Mathern, Gary W.;Levy, Susan R.
通讯作者:
Levy, Susan R.
影响因子:
5.6
作者:
Grosso, S;Galimberti, D;Balestri, P
通讯作者:
Balestri, P
影响因子:
5.6
作者:
Kwan, Patrick;Arzimanoglou, Alexis;French, Jacqueline
通讯作者:
French, Jacqueline